Evommune EVMN Operating Lease Liabilities (Total)
Operating Lease Liabilities (Total) at other companies
Other financials
Where this comes from
Reported directly by Evommune in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseLiability.
The official record: Evommune ’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →
Ask your AI about Evommune 's operating lease liabilities (total).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Evommune 's operating lease liabilities (total)?
- Evommune (EVMN) reported operating lease liabilities (total) of $1.72M in Q1 2026.
- What is the long-term trend for Evommune 's operating lease liabilities (total)?
- Over 2 years (2023 to 2025), Evommune 's operating lease liabilities (total) has grown at a -13.2% compound annual growth rate (CAGR), from $2.4M to $1.81M.
- What does operating lease liabilities (total) mean?
- This represents the total present value of future lease payments for operating leases, recognized as a liability on the balance sheet. It reflects the company's long-term commitment to leased assets such as office space, warehouses, and equipment. Tracking this helps investors evaluate the company's off-balance-sheet financing obligations and overall debt-like commitments.